• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BAP1通过去泛素化KLF5促进乳腺癌细胞增殖和转移。

BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.

作者信息

Qin Junying, Zhou Zhongmei, Chen Wenlin, Wang Chunyan, Zhang Hailin, Ge Guangzhe, Shao Ming, You Dingyun, Fan Zhixiang, Xia Houjun, Liu Rong, Chen Ceshi

机构信息

Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Collaborative Innovation Center for Cancer Medicine, Kunming, Yunnan 650223, China.

Graduate School of the Chinese Academy of Sciences, Beijing 100039, China.

出版信息

Nat Commun. 2015 Sep 30;6:8471. doi: 10.1038/ncomms9471.

DOI:10.1038/ncomms9471
PMID:26419610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4598844/
Abstract

The transcription factor KLF5 is highly expressed in basal-like breast cancer and promotes breast cancer cell proliferation, survival, migration and tumour growth. Here we show that, in breast cancer cells, KLF5 is stabilized by the deubiquitinase (DUB) BAP1. With a genome-wide siRNA library screen of DUBs, we identify BAP1 as a bona fide KLF5 DUB. BAP1 interacts directly with KLF5 and stabilizes KLF5 via deubiquitination. KLF5 is in the BAP1/HCF-1 complex, and this newly identified complex promotes cell cycle progression partially by inhibiting p27 gene expression. Furthermore, BAP1 knockdown inhibits tumorigenicity and lung metastasis, which can be rescued partially by ectopic expression of KLF5. Collectively, our findings not only identify BAP1 as the DUB for KLF5, but also reveal a critical mechanism that regulates KLF5 expression in breast cancer. Our findings indicate that BAP1 could be a potential therapeutic target for breast and other cancers.

摘要

转录因子KLF5在基底样乳腺癌中高表达,可促进乳腺癌细胞的增殖、存活、迁移及肿瘤生长。在此我们发现,在乳腺癌细胞中,去泛素化酶(DUB)BAP1可使KLF5稳定。通过对DUB进行全基因组siRNA文库筛选,我们确定BAP1为真正的KLF5 DUB。BAP1直接与KLF5相互作用,并通过去泛素化使KLF5稳定。KLF5存在于BAP1/HCF-1复合物中,这个新发现的复合物部分通过抑制p27基因表达促进细胞周期进程。此外,敲低BAP1可抑制肿瘤发生及肺转移,而异位表达KLF5可部分挽救这种抑制作用。总的来说,我们的研究结果不仅确定了BAP1为KLF5的DUB,还揭示了乳腺癌中调节KLF5表达的关键机制。我们的研究结果表明,BAP1可能是乳腺癌及其他癌症的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/7cd135fc0191/ncomms9471-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/824ba856eed8/ncomms9471-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/71857705380d/ncomms9471-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/79f69cbbf30c/ncomms9471-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/9d2688595ab8/ncomms9471-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/2eb100191b45/ncomms9471-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/7cd135fc0191/ncomms9471-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/824ba856eed8/ncomms9471-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/71857705380d/ncomms9471-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/79f69cbbf30c/ncomms9471-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/9d2688595ab8/ncomms9471-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/2eb100191b45/ncomms9471-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd31/4598844/7cd135fc0191/ncomms9471-f6.jpg

相似文献

1
BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.BAP1通过去泛素化KLF5促进乳腺癌细胞增殖和转移。
Nat Commun. 2015 Sep 30;6:8471. doi: 10.1038/ncomms9471.
2
USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.USP3 通过去泛素化 KLF5 促进乳腺癌细胞增殖。
J Biol Chem. 2019 Nov 22;294(47):17837-17847. doi: 10.1074/jbc.RA119.009102. Epub 2019 Oct 17.
3
Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).类ataxin-3(ATXN3L)是去泛素化酶约瑟芬家族的成员,通过去泛素化Krüppel样因子5(KLF5)促进乳腺癌增殖。
Oncotarget. 2015 Aug 28;6(25):21369-78. doi: 10.18632/oncotarget.4128.
4
BAP1 antagonizes WWP1-mediated transcription factor KLF5 ubiquitination and inhibits autophagy to promote melanoma progression.BAP1 拮抗 WWP1 介导的转录因子 KLF5 泛素化,抑制自噬,从而促进黑色素瘤进展。
Exp Cell Res. 2021 May 1;402(1):112506. doi: 10.1016/j.yexcr.2021.112506. Epub 2021 Jan 29.
5
BAP1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF-BP1.BAP1 通过 KLF5/CyclinD1/FGF-BP1 促进 ECA109 细胞的活力和迁移。
FEBS Open Bio. 2021 May;11(5):1497-1503. doi: 10.1002/2211-5463.13105. Epub 2021 Mar 28.
6
Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.Krüppel样因子5部分通过上调成纤维细胞生长因子结合蛋白1的转录来促进乳腺细胞增殖。
Oncogene. 2009 Oct 22;28(42):3702-13. doi: 10.1038/onc.2009.235. Epub 2009 Aug 10.
7
The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.BAP1/ASXL2组蛋白H2A去泛素化酶复合物调控细胞增殖并在癌症中失调。
J Biol Chem. 2015 Nov 27;290(48):28643-63. doi: 10.1074/jbc.M115.661553. Epub 2015 Sep 28.
8
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.组蛋白去乙酰化酶抑制剂(HDACi)促进基底样乳腺癌中 KLF5 的泛素化和降解。
Int J Biol Sci. 2022 Feb 28;18(5):2104-2115. doi: 10.7150/ijbs.65322. eCollection 2022.
9
The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.Fbw7 肿瘤抑制因子靶向 KLF5 进行泛素介导的降解,从而抑制乳腺细胞增殖。
Cancer Res. 2010 Jun 1;70(11):4728-38. doi: 10.1158/0008-5472.CAN-10-0040. Epub 2010 May 18.
10
The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.泛素羧基末端水解酶 BAP1 与 YY1 和 HCF-1 形成三元复合物,是基因表达的关键调节剂。
Mol Cell Biol. 2010 Nov;30(21):5071-85. doi: 10.1128/MCB.00396-10. Epub 2010 Aug 30.

引用本文的文献

1
Circular RNA hsa_Circ_0007552 inhibits lung adenocarcinoma proliferation, migration and invasion via the miR-7974/BAP1 axis.环状RNA hsa_Circ_0007552通过miR-7974/BAP1轴抑制肺腺癌的增殖、迁移和侵袭。
Front Immunol. 2025 Aug 21;16:1634326. doi: 10.3389/fimmu.2025.1634326. eCollection 2025.
2
A novel SWI/SNF complex promotes triple-negative breast cancer progression.一种新型的SWI/SNF复合物促进三阴性乳腺癌进展。
Cell Mol Biol Lett. 2025 Sep 1;30(1):105. doi: 10.1186/s11658-025-00788-6.
3
Molecular regulation by ubiquitin-specific proteases (USPs) in HCC: cell cycle, oncogenic signaling, and beyond.

本文引用的文献

1
Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis.在正常 DNA 合成过程中,BAP1 将 INO80 稳定并靶向复制叉。
Nat Commun. 2014 Oct 6;5:5128. doi: 10.1038/ncomms6128.
2
Deubiquitination of γ-tubulin by BAP1 prevents chromosome instability in breast cancer cells.BAP1 对 γ-微管蛋白的去泛素化作用可防止乳腺癌细胞中的染色体不稳定性。
Cancer Res. 2014 Nov 15;74(22):6499-508. doi: 10.1158/0008-5472.CAN-14-0221. Epub 2014 Sep 16.
3
USP9X downregulation renders breast cancer cells resistant to tamoxifen.
泛素特异性蛋白酶(USP)在肝癌中的分子调控:细胞周期、致癌信号传导及其他方面。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 23. doi: 10.1007/s00210-025-04395-2.
4
UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1.泛素样修饰因子化通过激活去泛素化酶BAP1来维持肿瘤抑制因子pVHL的稳定性。
Sci Adv. 2025 Jul 11;11(28):eadt8800. doi: 10.1126/sciadv.adt8800.
5
USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability.USP44通过EZH2蛋白稳定性促进三阴性乳腺癌的化疗耐药性。
Cancer Biol Ther. 2025 Dec;26(1):2529652. doi: 10.1080/15384047.2025.2529652. Epub 2025 Jul 6.
6
O-GlcNAcylation of FOXK1 co-opts BAP1 to orchestrate the E2F pathway and promotes oncogenesis.FOXK1的O-连接N-乙酰葡糖胺化作用借助BAP1来协调E2F信号通路并促进肿瘤发生。
Nat Commun. 2025 Jul 1;16(1):5959. doi: 10.1038/s41467-025-61022-7.
7
Porphyromonas gingivalis potentiates stem-like properties of oral squamous cell carcinoma by modulating SCD1-dependent lipid synthesis via NOD1/KLF5 axis.牙龈卟啉单胞菌通过NOD1/KLF5轴调节硬脂酰辅酶A去饱和酶1(SCD1)依赖性脂质合成,增强口腔鳞状细胞癌的干细胞样特性。
Int J Oral Sci. 2025 Feb 28;17(1):15. doi: 10.1038/s41368-024-00342-8.
8
NAT10 Promotes Gastric Cancer Liver Metastasis by Modulation of M2 Macrophage Polarization and Metastatic Tumor Cell Hepatic Adhesion.NAT10 通过调节 M2 巨噬细胞极化和转移性肿瘤细胞肝黏附促进胃癌肝转移。
Adv Sci (Weinh). 2025 Apr;12(15):e2410263. doi: 10.1002/advs.202410263. Epub 2025 Feb 22.
9
Portrait of WWP1: the current state in human cancer.WWP1简介:人类癌症的现状
Front Cell Dev Biol. 2025 Jan 30;12:1516613. doi: 10.3389/fcell.2024.1516613. eCollection 2024.
10
Positive Feedback Regulation between KLF5 and XPO1 Promotes Cell Cycle Progression of Basal like Breast Cancer.KLF5与XPO1之间的正反馈调节促进基底样乳腺癌的细胞周期进程。
Adv Sci (Weinh). 2025 Apr;12(16):e2412096. doi: 10.1002/advs.202412096. Epub 2025 Jan 30.
USP9X 的下调使乳腺癌细胞对他莫昔芬产生耐药性。
Cancer Res. 2014 Jul 15;74(14):3810-20. doi: 10.1158/0008-5472.CAN-13-1960.
4
Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.染色体 3 状态联合 BAP1 和 EIF1AX 突变谱与葡萄膜黑色素瘤的转移相关。
Invest Ophthalmol Vis Sci. 2014 Jun 26;55(8):5160-7. doi: 10.1167/iovs.14-14550.
5
Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.自泛素化保护肿瘤抑制因子 BAP1 免于被非典型泛素连接酶 UBE2O 介导的细胞质隔离。
Mol Cell. 2014 May 8;54(3):392-406. doi: 10.1016/j.molcel.2014.03.002. Epub 2014 Apr 3.
6
KLF5 regulates the integrity and oncogenicity of intestinal stem cells.KLF5 调节肠道干细胞的完整性和致癌性。
Cancer Res. 2014 May 15;74(10):2882-91. doi: 10.1158/0008-5472.CAN-13-2574. Epub 2014 Mar 13.
7
Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair.抑癌基因和去泛素化酶 BAP1 促进 DNA 双链断裂修复。
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):285-90. doi: 10.1073/pnas.1309085110. Epub 2013 Dec 17.
8
Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.Kruppel 样因子 5 转录因子促进乳腺癌中微粒体前列腺素 E2 合酶 1 基因的转录。
J Biol Chem. 2013 Sep 13;288(37):26731-40. doi: 10.1074/jbc.M113.483958. Epub 2013 Aug 2.
9
BAP1 and cancer.BAP1 与癌症。
Nat Rev Cancer. 2013 Mar;13(3):153-9. doi: 10.1038/nrc3459.
10
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.